Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...

VANCOUVER, BRITISH COLUMBIA, CANADA, April 21, 2025 /EINPresswire.com/ -- Global readers fall in love with Petey the Pug, as ...